Innogenetics Bid Could Give Gen-Probe A Larger Slice Of European Pie
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe's offer to acquire Belgian molecular assay maker Innogenetics for about $334 million, announced June 3, would nearly double the diagnostics firm's international sales and give it a larger piece of the rapidly expanding European market